Graham Capital Management, L.P. Edwards Lifesciences Corp Transaction History

Graham Capital Management, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 22, 2023	SELL	$69.28 - $93.38 $352,011 - $474,463	-5,081 Reduced 63.47%	2,924 $202,000
Q2 2023 Aug 14, 2023	BUY	$81.41 - $94.33 $651,687 - $755,111	8,005 New	8,005 $755,000
Q4 2022 Feb 14, 2023	SELL	$68.3 - $87.44 $102,859 - $131,684	-1,506 Reduced 10.58%	12,732 $949,000
Q3 2022 Nov 14, 2022	BUY	$82.37 - $107.29 $1.17 Million - $1.53 Million	14,238 New	14,238 $1.18 Million

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Graham Capital Management, L.P. with notifications on news.